Related Research


Increased Risk of Breast Cancer Recurrence in Women initiating Tamoxifen with CYP2D6 inhibitors


External link:* https://www.medcoresearch.com/community/oncology

Study examining the impact CYP2D6 inhibitor medications have on breast cancer recurrence rates in women treated with tamoxifen.

Author: Ronald E. Aubert, PhD,1 Eric J. Stanek, PharmD,1 Jianying Yao, MS,1 J. Russell Teagarden, MA, DMH,1 Milayna Subar, MD,1 Robert S. Epstein, MD,1 Todd C. Skaar, PhD,2 Zeruesenay Desta, PhD,2 David A. Flockhart, MD, PhD.2

Related numbers to fix: 192,370

Breast cancer and SSRI's


External link:* http://bit.ly/es1w8

Medco study uncovers link between breast cancer recurrence and tamoxifen inhibition caused by SSRI's



Related numbers to fix: 192,370

Breast Cancer Facts


External link:* http://ww5.komen.org/uploadedFiles/Content_Binaries/BreastCancerFacts2009.pdf

Susan G. Komen for The Cure details breast cancer facts, including the number of estimated diagnosed cases of invasive breast cancer in women in the U.S. during 2008.

Author: Susan G. Komen for The Cure

Related numbers to fix: 192,370
divider
* By selecting an external link, you will be leaving the Making Medicine Smarter website and linking to another website which may be governed by a separate and different Terms of Use and Privacy Policy.

Medco is a registered trademark and Medco Making Medicine Smarter is a trademark of Medco Health Solutions, Inc.
Copyright 2009 Medco Health Solutions, Inc. All Rights Reserved.